Aortic valve
The one-way door at the exit of the left ventricle: it opens in systole to let the whole left ventricular output into the aorta, and shuts in diastole so that blood does not fall back into the ventricle.
What it normally does
Three thin cusps open to roughly 3 to 4 cm² in an adult — a door wide enough that blood crosses it with almost no resistance, so left ventricular and aortic pressure during ejection are within a few mmHg of each other.
when the orifice narrows, any pressure difference measured across the valve has to be generated by the ventricle itself — that gradient, and the hypertrophy the ventricle builds to sustain it, is aortic stenosis.
It shuts at the start of diastole, when aortic pressure exceeds the falling ventricular pressure. That closure is the first and normally the louder component of the second heart sound (A2), and it is what holds the column of blood up in the aorta through diastole.
a valve whose cusps no longer meet lets that column fall back into the ventricle (aortic regurgitation), while a valve too calcified and immobile to snap shut makes A2 soft or inaudible in severe stenosis.
The coronary ostia open from the right and left aortic sinuses, above the cusp attachments, and left ventricular myocardium is perfused almost entirely in diastole, when the muscle is relaxed and the shut valve is holding aortic pressure up. Left coronary flow therefore tracks aortic diastolic pressure much more closely than systolic — the thinner-walled right ventricle, at far lower wall tension, keeps some perfusion through systole.
anything that raises left ventricular diastolic pressure, or drops aortic diastolic pressure, starves the subendocardium — which is why aortic stenosis and aortic regurgitation both cause angina with angiographically clean coronaries.
Each beat pushes a stroke volume of roughly 70 mL into the aorta, which stretches and then recoils. The pulse pressure (systolic minus diastolic, normally around 40 mmHg) is set by three things: the size of that stroke volume, the compliance of the aorta, and how fast blood runs off during diastole.
the pulse changes shape in valve disease — narrow and slow-rising when a stenosed valve limits stroke volume, wide and collapsing when a leaking valve inflates stroke volume and drains the aorta in diastole — but because arterial stiffness moves it independently, the pulse raises the question rather than answering it.
The cusps are thin and avascular, and competence depends on broad coaptation of their free edges within an aortic root of normal calibre, with commissures that stay unfused. Damaged valve tissue is not regenerated.
calcification, congenital bicuspid geometry, rheumatic commissural fusion, root dilatation and endocarditic destruction all end in stenosis, regurgitation or both — and none of them is reversed by drugs, which is why the definitive treatment is mechanical.
What goes wrong
- Aortic stenosis← from “Three thin cusps open to roughly 3 to 4 cm² in…”
Decades of calcium deposition on the cusps (or a bicuspid valve, or old rheumatic damage) stiffen them so they no longer open fully. The wide, free door becomes a narrow hole, so the ventricle must generate a large pressure gradient to push the same stroke volume out. It responds with concentric hypertrophy, and thick muscle working at high pressure demands more oxygen while the raised diastolic pressure inside the ventricle squeezes the subendocardial bed it depends on. Hence the triad: angina from supply-demand mismatch even with normal coronary arteries; exertional syncope, largely because the obstruction is fixed, so when exercising muscle vasodilates the heart cannot raise output to match and cerebral perfusion falls (an exercise-triggered vasodepressor reflex and arrhythmia can contribute); and breathlessness and heart failure, because a stiff hypertrophied ventricle fills at high pressure and that pressure backs up into the lungs.
Severity on echo: mean gradient ≥40 mmHg, peak velocity ≥4 m/s, or valve area ≤1.0 cm² — but low-flow, low-gradient severe stenosis exists, so a gradient under 40 mmHg with a small stroke volume does not exclude severe disease. Symptoms change everything: the classic quoted mean survival untreated is about 5 years after angina, 3 after syncope and 2 after heart failure, and symptomatic severe stenosis is a referral for valve replacement (surgical or TAVI), not a prescription.
You would find: A harsh ejection systolic murmur at the right second intercostal space radiating to the carotids, classically with a slow-rising, low-volume pulse (pulsus parvus et tardus), a narrow pulse pressure, and a soft or absent A2 — the tighter and more immobile the valve, the quieter A2. Those pulse signs have a real limit: stiff arteries in an older patient can keep the upstroke brisk and the pulse pressure normal or even wide despite severe stenosis, so a normal-feeling pulse does not exclude it in exactly the age group where the disease is commonest. The symptom history — angina, blackouts on exertion, breathlessness — is the turning point, and echocardiography is what settles severity.
- Chronic aortic regurgitation← from “It shuts at the start of diastole, when aortic…”
The cusps no longer meet in diastole — a bicuspid valve, rheumatic scarring, or an aortic root that has dilated and pulled the cusps apart — so blood falls back into the ventricle. The ventricle ejects its normal filling plus the regurgitant volume, so total stroke volume becomes very large and the chamber dilates over years to hold it (eccentric hypertrophy), which is why the patient can stay asymptomatic for a long time. Two consequences follow directly: systolic pressure rises because the ejected volume is large, and diastolic pressure falls because blood leaks backwards out of the aorta instead of staying in it. That gives the wide pulse pressure and the collapsing pulse. Low aortic diastolic pressure and a high ventricular diastolic pressure also narrow the coronary perfusion gradient, so angina can occur. Eventually the dilated ventricle decompensates and the patient becomes breathless.
Wide pulse pressure plus early diastolic murmur; echo defines severity and, just as importantly, the aortic root. Timing of surgery is driven by symptoms, or in asymptomatic severe regurgitation by falling left ventricular systolic function or progressive dilatation — the ACC/AHA threshold is an ejection fraction of 55% or less, the ESC 50% or less, with left ventricular end-systolic dimension above about 50 mm as the other trigger. Vasodilator drugs treat blood pressure and the failing ventricle; they do not remove the indication for surgery.
You would find: A soft early diastolic murmur at the left sternal edge, best heard with the patient sitting forward in held expiration, with a wide pulse pressure and a collapsing (water hammer) pulse. The peripheral eponyms are the same physiology restated — head nodding (de Musset), nail bed capillary pulsation (Quincke), a visibly pulsating carotid (Corrigan) — and they are insensitive, so their absence proves little.
- Acute severe aortic regurgitation← from “It shuts at the start of diastole, when aortic…”
A cusp is destroyed suddenly — a vegetation perforates it in infective endocarditis, or a type A aortic dissection tears the root apart. The ventricle has had no time to dilate, so the regurgitant volume arrives in a normal-sized, relatively non-compliant chamber; its diastolic pressure climbs steeply and that pressure is transmitted back into the pulmonary circulation. Because total stroke volume never has the chance to become large, the wide pulse pressure and collapsing pulse of the chronic form are typically absent, and the murmur is short and quiet because ventricular and aortic diastolic pressures equalise early.
Acute severe regurgitation = pulmonary oedema with an unimpressive pulse and an unimpressive murmur. Endocarditis or dissection until proven otherwise; management is urgent surgery, and vasodilators or inotropes are only a bridge to it.
You would find: Sudden breathlessness, pulmonary oedema, tachycardia and shock, sometimes with fever, and only a short soft murmur — occasionally a soft first heart sound from premature mitral valve closure. A normal-looking pulse pressure does not exclude it. The trap is expecting it to look like chronic regurgitation; this is a surgical emergency needing urgent echocardiography and cardiothoracic involvement.
- Bicuspid aortic valve← from “The cusps are thin and avascular, and competen…”
The valve forms with two functional cusps instead of three, in roughly 1 to 2% of people and about two to three times more often in men — the commonest congenital valve lesion (ventricular septal defect is the commonest congenital heart defect diagnosed in infancy). Two cusps means asymmetric, turbulent flow and abnormal leaflet mechanics, and that stress accelerates calcification, so these valves tend to become stenotic one to two decades earlier than three-cusp valves: bicuspid disease dominates severe aortic stenosis presenting in the fifties and sixties, while calcific stenosis of a three-cusp valve typically presents in the seventies and eighties. Bicuspid valves may also be regurgitant. The associated aortopathy affects the wall of the ascending aorta, which can dilate and dissect independently of how the valve itself is functioning.
Young-to-middle-aged aortic stenosis, or an incidental click and murmur: think bicuspid, then image the aorta and screen the family. Valve severity and aortic diameter are followed separately.
You would find: An ejection click followed by a systolic murmur (with or without an early diastolic murmur) in a young or middle-aged person, often found incidentally. Imaging of the ascending aorta and root matters as much as the valve, because the aorta can be the lesion that kills. Because it clusters in families, guidelines recommend echocardiographic screening of first-degree relatives.
- Rheumatic aortic valve disease← from “The cusps are thin and avascular, and competen…”
After group A streptococcal infection — classically pharyngitis, and in high-burden Australian settings skin infection (impetigo) is also implicated — the immune response cross-reacts with valve tissue. Repeated episodes of acute rheumatic fever fuse the cusps at their commissures and scar and retract them, so the valve both fails to open fully and fails to close fully: mixed stenosis and regurgitation, usually alongside mitral disease, which is the valve most often affected. In Australia this is not a historical curiosity — Aboriginal and Torres Strait Islander peoples carry among the highest rates of acute rheumatic fever and rheumatic heart disease in the world, and it presents in children and young adults rather than the elderly.
Mixed aortic stenosis and regurgitation with mitral disease in a young Aboriginal or Torres Strait Islander patient = rheumatic until proven otherwise. Diagnosis of the acute episode is clinical plus echo; the long game is register-based secondary prophylaxis, because it is the repeat attacks that fix the valve damage.
You would find: A young patient with both a systolic and a diastolic murmur, usually with mitral involvement. A child or young adult with a new murmur, fever and migratory joint pain needs acute rheumatic fever actively excluded (Jones criteria, echocardiography, streptococcal serology). Acute rheumatic fever and rheumatic heart disease are notifiable in the Australian jurisdictions that run register-based control programs, and confirmed cases are entered on those registers so that secondary prophylaxis is delivered and tracked.
What we give, and how it works
Open a drug to see what it binds, what that does to the cell, and what you then see in the patient.
- Binds
- Bioactivated intracellularly (glyceryl trinitrate largely by mitochondrial aldehyde dehydrogenase) to release nitric oxide, which binds soluble guanylate cyclase in vascular smooth muscle.
- Which does
- Raised cyclic GMP activates protein kinase G, lowering intracellular calcium and dephosphorylating myosin light chains, so the cell relaxes — most sensitively in venous capacitance vessels.
- So you see
- Venodilatation reduces preload and ventricular wall stress, so myocardial oxygen demand falls and angina eases; coronary epicardial dilatation adds a smaller supply-side benefit.
- And the same mechanism causes
- The same vasodilatation elsewhere: throbbing headache from meningeal and cerebral vessel dilatation, flushing, postural hypotension with reflex tachycardia — and, where cardiac output depends on preload (severe aortic stenosis, hypertrophic obstructive physiology, right ventricular infarction), profound hypotension.
- Handling
- Continuous exposure produces tolerance within about 24 hours, so long-acting nitrate regimens are built around a daily nitrate-free interval.
Catches people out: This is the classic trap. In severe aortic stenosis the outflow is a fixed orifice, so the ventricle cannot raise its output to compensate when preload and blood pressure drop; sublingual glyceryl trinitrate given for chest pain in someone with a slow-rising pulse and an ejection murmur can cause abrupt hypotension and syncope. The pulse and the murmur are worth assessing before nitrates are used in undifferentiated chest pain.
- Binds
- ACE (kininase II) on endothelial cell surface for the inhibitors; the AT1 G-protein-coupled receptor for the blockers.
- Which does
- Less angiotensin II is generated (or less of it can signal), so vascular smooth muscle Gq signalling and aldosterone release fall; ACE inhibition additionally allows bradykinin to accumulate.
- So you see
- Arteriolar dilatation and lower systemic vascular resistance, less sodium and water retention, and reduced ventricular remodelling — clinically, lower blood pressure and a smaller regurgitant fraction.
- And the same mechanism causes
- Loss of efferent arteriolar constriction drops glomerular filtration (marked in bilateral renal artery stenosis) and loss of aldosterone drive causes hyperkalaemia — both classes. Accumulated bradykinin explains the dry cough and angio-oedema seen with ACE inhibitors and largely not with receptor blockers, which is precisely why intolerant patients are switched across.
- Handling
- Angiotensin II maintains efferent glomerular arteriolar tone, so renal function and potassium are checked after starting or increasing the dose; both classes are contraindicated in pregnancy.
Catches people out: No drug repairs a valve; these treat blood pressure and the ventricle and do not replace or delay surgical referral. In severe aortic stenosis they are no longer regarded as contraindicated — hypertension is common and needs treating — but they are introduced at low dose and titrated slowly, because a sharp fall in systemic resistance across a fixed obstruction reduces coronary and cerebral perfusion.
- Binds
- NKCC2 in the thick ascending limb, binding the chloride site of the cotransporter.
- Which does
- Sodium, potassium and chloride reabsorption is abolished in that segment, and with it the medullary concentration gradient, so the kidney can neither concentrate nor dilute urine effectively.
- So you see
- Brisk natriuresis and diuresis, falling venous and pulmonary capillary pressure, and relief of orthopnoea and oedema; the venodilator effect gives some symptomatic benefit before the urine appears.
- And the same mechanism causes
- Increased distal sodium delivery drives potassium and hydrogen ion exchange, giving hypokalaemia and metabolic alkalosis; magnesium and calcium reabsorption in that segment is lost too, causing hypomagnesaemia and hypocalcaemia; and excessive volume loss causes hypotension and prerenal impairment — worst in the preload-dependent stenotic ventricle. NKCC1 in the inner ear explains the dose-related ototoxicity.
- Handling
- Oral bioavailability is variable and gut wall oedema in decompensated failure reduces absorption, which is why the intravenous route is used in acute pulmonary oedema.
Catches people out: The thick, stiff, poorly compliant ventricle of aortic stenosis depends on adequate filling to eject at all. Over-diuresis empties it, and cardiac output and blood pressure fall with it — the aim is to relieve congestion rather than to render the patient volume-depleted.
- Binds
- β1 adrenoceptor, a Gs-coupled receptor, competitively antagonised (bisoprolol the most β1-selective of the three, metoprolol selective at lower doses, atenolol selective and renally cleared).
- Which does
- Less adenylyl cyclase activity means less cyclic AMP and less protein kinase A phosphorylation of L-type calcium channels and the pacemaker current, so nodal firing slows and myocyte calcium entry falls.
- So you see
- Lower heart rate, lower contractility and blood pressure, reduced myocardial oxygen demand, and a gentler pressure wave striking the aortic wall.
- And the same mechanism causes
- The intended blockade taken further: bradycardia and heart block, fatigue and blunted exercise heart rate, cold extremities, and in aortic regurgitation a longer diastole and therefore a larger regurgitant volume each beat. β2 spillover at higher doses can provoke bronchospasm and mask the adrenergic warning signs of hypoglycaemia.
Catches people out: Slowing the heart lengthens diastole, which is exactly when an incompetent aortic valve leaks, so in significant aortic regurgitation bradycardia can increase the volume regurgitated per beat; beta blockade is not the reflex choice here that it is elsewhere in cardiology. In severe aortic stenosis with a stiff, hypertrophied ventricle, the negative inotropic effect is also poorly tolerated if pushed.
- Binds
- Bacterial penicillin-binding proteins (transpeptidases) in the streptococcal cell wall; there is no human target.
- Which does
- Cross-linking of peptidoglycan is blocked and autolysins are unopposed, so dividing organisms lyse — group A streptococcus has remained uniformly penicillin-susceptible.
- So you see
- Streptococcal infection is prevented, so the antigenic trigger for the cross-reactive immune attack on the valve does not recur and the valve lesion stops progressing from repeat attacks.
- And the same mechanism causes
- Because the target is bacterial, systemic toxicity is minimal; the problems come from the depot and from immune recognition of the beta-lactam — a painful injection site, and hypersensitivity ranging from rash to anaphylaxis, which is why a documented penicillin allergy is properly assessed rather than assumed before an alternative regimen is chosen.
- Handling
- The benzathine salt is a depot with slow release from the injection site, which is what allows dosing measured in weeks rather than hours — it must not be given intravenously.
Catches people out: It prevents further damage; it does not reverse damage already done, and no antibiotic regimen is fully protective if doses are missed. It is given as a deep intramuscular injection on a schedule running for years — typically a minimum of ten years after the last episode or until a specified age, and longer where there is established valve disease — so adherence is the whole battle, and it is delivered through the state and territory rheumatic heart disease control programs and registers (Therapeutic Guidelines and the Australian ARF/RHD guideline carry the current regimen and duration). Separately, routine antibiotic cover before dental procedures is no longer recommended for a bicuspid valve alone: Australian guidance reserves it for the highest-risk groups, which include prosthetic valves and prosthetic material, previous infective endocarditis, some unrepaired congenital lesions, and rheumatic heart disease in Aboriginal and Torres Strait Islander patients.
Let the pulse raise the question and let the echocardiogram answer it: narrow and slow-rising suggests stenosis, wide and collapsing suggests chronic regurgitation — but stiff arteries in an older patient can hide the slow upstroke and widen the pulse pressure despite a severely stenosed valve, and acute severe regurgitation has neither sign. Then remember the limits of drugs here: once severe aortic stenosis becomes symptomatic (angina, syncope or heart failure), no medical therapy has been shown to alter the natural history, and the classic quoted untreated survival is only a few years. The treatment is a new valve, surgical or transcatheter (TAVI); the drugs on this page manage congestion and comorbidity while that is arranged — and one of them, glyceryl trinitrate given to an undiagnosed severe stenosis, can precipitate collapse.
Now test whether it stuck
Reading this through is not the same as being able to reconstruct it. Every question in the bank is free, with a full debrief on each option.